Clear Impact logo

Vermont Medicaid

OHD: Use of Opioids at High Dosage - Age 18+ (ACS-MY22)

Current Value

10.8%

MY 2022

Definition

Line Bar

Notes on Methodology

  • This is a Pharmacy Quality Alliance (PQA) administrative measure.  PQA performance measures are grouped into the domains of Adherence, Appropriate Medication Use, Medication Safety, and Medication Therapy management.  PQA has two core measure sets focused on opioid prescribing and specialty medications.
  • The annual reported rate captures activity during the stated measurement year (MY).

Story Behind the Curve

Rate per 1,000 Medicaid enrollees age 18 and older without cancer who received prescriptions for opioids with a daily dosage greater than 120 mg morphine equivalent dose (MED) for 90 consecutive days or longer.

Last updated:  August 2021

Clear Impact Suite is an easy-to-use, web-based software platform that helps your staff collaborate with external stakeholders and community partners by utilizing the combination of data collection, performance reporting, and program planning.

Scorecard Container Measure Action Actual Value Target Value Tag S A m/d/yy m/d/yyyy